176 related articles for article (PubMed ID: 23980047)
21. [The RAS paradox of the EGFR-targeted therapy in colorectal cancer].
Tímár J; Láng I
Magy Onkol; 2008 Jun; 52(2):185-91. PubMed ID: 18640895
[TBL] [Abstract][Full Text] [Related]
22. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
László L
Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
[TBL] [Abstract][Full Text] [Related]
23. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
Herz C; Schlürmann F; Batarello D; Fichter CD; Schöpflin A; Münch C; Hauschke D; Werner M; Lassmann S
Mol Carcinog; 2012 Sep; 51(9):696-710. PubMed ID: 21739483
[TBL] [Abstract][Full Text] [Related]
24. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
25. No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines.
Danielsen T; Smith-Sørensen B; Grønlund HA; Hvidsten M; Børresen-Dale AL; Rofstad EK
Int J Radiat Biol; 1999 Sep; 75(9):1149-60. PubMed ID: 10528923
[TBL] [Abstract][Full Text] [Related]
26. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates.
Hu Q; Hill RP
Radiat Res; 1996 Dec; 146(6):636-45. PubMed ID: 8955713
[TBL] [Abstract][Full Text] [Related]
28. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells.
Wang XK; Zhou FF; Tao HR; Wang X; Zhang C; Su F; Wang SP; Xu LH; Pan XK; Feng MH; Xie W
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):880-885. PubMed ID: 29270747
[TBL] [Abstract][Full Text] [Related]
30. [Long non-coding RNA influences radiosensitivity of colorectal carcinoma cell lines by regulating cyclin D1 expression].
Yu ZQ; Zhang C; Lao XY; Wang H; Gao XH; Cao GW; Zhou WP; Fu CG
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):288-91. PubMed ID: 22454180
[TBL] [Abstract][Full Text] [Related]
31. [Down regulation of multidrug resistance-associated protein 4 expression by RNA interference enhances radiosensitivity of colorectal carcinoma cell lines in vitro].
Yu ZQ; Zhang C; Cai R; Lao XY; Wang H; Gao XH; Han YF; Zhang XQ; Cao GW; Fu CG
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jan; 15(1):67-71. PubMed ID: 22287356
[TBL] [Abstract][Full Text] [Related]
32. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
Monstein HJ; Fransén K; Dimberg J; Söderkvist P
Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
[TBL] [Abstract][Full Text] [Related]
33. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
[TBL] [Abstract][Full Text] [Related]
34. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
[TBL] [Abstract][Full Text] [Related]
35. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
[TBL] [Abstract][Full Text] [Related]
36. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
37. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa).
Burdak-Rothkamm S; Rübe CE; Nguyen TP; Ludwig D; Feldmann K; Wiegel T; Rübe C
Strahlenther Onkol; 2005 Mar; 181(3):197-204. PubMed ID: 15756525
[TBL] [Abstract][Full Text] [Related]
39. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.
Pietrantonio F; Petrelli F; Coinu A; Di Bartolomeo M; Borgonovo K; Maggi C; Cabiddu M; Iacovelli R; Bossi I; Lonati V; Ghilardi M; de Braud F; Barni S
Eur J Cancer; 2015 Mar; 51(5):587-94. PubMed ID: 25673558
[TBL] [Abstract][Full Text] [Related]
40. Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Igarashi H; Kurihara H; Mitsuhashi K; Ito M; Okuda H; Kanno S; Naito T; Yoshii S; Takahashi H; Kusumi T; Hasegawa T; Sukawa Y; Adachi Y; Okita K; Hirata K; Imamura Y; Baba Y; Imai K; Suzuki H; Yamamoto H; Nosho K; Shinomura Y
Ann Surg Oncol; 2015 Aug; 22(8):2640-8. PubMed ID: 25472647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
